This study focuses on the market side of research antibodies rather than the technical side. Different market segments for this specific market are covered. For example, application-based market segments include enzyme-linked immunosorbent assay (ELISA), western blotting (WB), immunohistochemistry (IHC), immunofluorescent staining (IF) and flow cytometry (FC); antibody function-based market segments include primary antibodies and secondary antibodies; antibody clonality-based market segments include polyclonal antibodies and monoclonal antibodies, including oligoclonal antibodies; customer type-based market segments include universities/academic institutions, pharmaceutical/ biotech companies and other types of customers such as governmental research labs and CROs; geography-based market segments include North America, Europe, Asia-Pacific, and Rest of World. Research and market trends are also extrapolated by analyzing the funding, patent publications and sales trends of major players in the field.
In this report, the market for research antibodies is segmented based on product type, major reactivities, applications, and geography. Based on product type, the market is segmented into cell wall inhibitors, protein inhibitors, DNA inhibitors, and other inhibitors (RNA, Mycolic Acid, Folic Acid). Based on major reactivities, the market is segmented into oral and topical. The market is also presented based on application type, which is further segmented into human and veterinary.
By geography, the market has been segmented into the North America, Europe, Asia-Pacific, and Rest of the World (South America, and the Middle East and Africa) regions. Detailed analysis of major countries such as the U.S., Germany, the U.K., Italy, France, Spain, Japan, China, India, Brazil, Mexico, GCC countries, and South Africa will be covered in the regional segment. For market estimates, data will be provided for 2019 as the base year, with estimates for 2020 and forecast value for 2025.
64 data tables and 25 additional tables
An overview of the global market for research antibodies
Estimation of the market size and analyses of global market trends, with data from 2018, 2019, 2020 and projections of compound annual growth rates (CAGRs) through 2025
Discussion on the factors affecting the companies' market shares, the current strategies of antibody companies, the effect of research funding, and the third-party quality evaluation systems of research antibodies
Description of antibody technologies, emerging antibody generation technologies and identification of market drivers, restraints and other forces impacting the global market
Market share analysis of research antibodies based on product, clonality, application, end-user and region and evaluation of current market trends, market size and forecast
Discussion on technological trends in antibody production and application, and information on antibody-based drug discovery and development process
Impact analysis of COVID-19 on entire pharma industry and discussion on how COVID-19 is related to pharmaceutical industry's growth slow-down and results in delayed approvals for non-COVID-19-related pharmaceutical/biotech products
Coverage of FDA and international regulations, details of recent regulatory reforms and list of antibody therapeutics granted in 2018 and insights into government initiatives and funding in emerging markets
Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies
Company profiles of major players of the industry, including Merck KGaA, Thermo Fisher Scientific, United States Biological, Beckman Coulter Inc., Agilent Technologies Inc. and Cell Signaling Technology
The high growth rate of this segment is attributed to factors such as the demand for antibodies research, the expanding pandemic of COVID-19, other infectious diseases, and an increase in R&D activities by key companies to emerge with new antibodies to counter the rise in different infectious diseases globally. Moreover, the advancement of biological discoveries will result inthe need for more molecular targets to be detected by their antibodies. For example, even for the same protein molecule, antibodies for each of its many forms of post-translational modifications are needed. This is likely to propel the growth of the research antibodies market during the forecast period.
Primary antibodies are used alone or in combination with a secondary antibody. For instance, primary antibodies conjugated to fluorochromes are used in flow cytometry, whereas in microscopy, a primary-secondary antibody combination is used to increase the signal.
According to Antibiotic.com, one supplier of antibodies states that primary antibodies can be used against any antigen including proteins, peptides, carbohydrates, and other small molecules. Primary antibodies can also be raised to recognize post-translational modifications such as phosphorylation, acetylation, methylation, and glycosylation.
A rise in basic or clinical research to detect specific cell or tissue components (antigens), a shorter assay time, an increase in the versatility, antigen signal detection, and amplification are the factors likely to fuel the growth of the segment in the next few years.
Key Topics Covered:
Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Chapter 2 Summary and Highlights
Chapter 3 Market and Technology Background
History and Current State
Background of the Antibody and Its Production
Current Status and Issues
Overview of Antibody Technology
Traditional Antibody Generation Technologies
Emerging Antibody Generation Technologies
Antibody Validation Methods
Trends in the Market for Research Antibodies
Purchasing Factors Analysis
Third-Party Quality Evaluation Systems
Journal Citations Analysis
Technological Trends in Antibody Production and Application
Deals within Last Decade Related to the Research Antibody Industry
WuXi App Tec Acquires Abgent
Abcam Acquires Epitomics
Agilent Acquires Dako
Affymetrix Acquires eBioscience
Bio-Rad Acquires AbD Serotec
Active Motif Acquires SwitchGear Genomics Inc.
Thermo Fisher Pierce Antibodies Merges with Life Technologies Corp.
Fluidigm Acquires DVS Sciences
Bio-Techne (R&D Systems) Acquires Novus Biologicals